Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription

Articles published in J Rheumatol

Retrieve available abstracts of 95 articles:
HTML format

Single Articles

    November 2022
  1. WANG G, Zhuo N, Wen Z
    Clinically Active Rheumatoid Arthritis and the Presence of Cardiovascular Disease Are Associated With an Elevated Risk of Dementia Incidence.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220934. doi: 10.3899/jrheum.220934.
    PubMed     Abstract available

  2. KLOSE-JENSEN R, Therkildsen J, Blavnsfeldt AG, Langdah B, et al
    The minimal erosive volume needed for radiographic identification of erosions in the metacarpophalangeal joints in patients with rheumatoid arthritis.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220623. doi: 10.3899/jrheum.220623.
    PubMed     Abstract available

  3. DUMOULIN QA, Verstappen M, van der Helm van Mil AHM, van Steenbergen HW, et al
    Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220531. doi: 10.3899/jrheum.220531.
    PubMed     Abstract available

  4. LANGE A, Kostadinova L, Damjanovska S, Gad I, et al
    Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis.
    J Rheumatol. 2022 Nov 1. pii: jrheum.211411. doi: 10.3899/jrheum.211411.
    PubMed     Abstract available

  5. TAKANASHI S, Takeuchi T, Kaneko Y
    Impacts of ageing on rheumatoid factor and anti-cyclic citrullinated peptide antibody positivity in patients with rheumatoid arthritis.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220526. doi: 10.3899/jrheum.220526.
    PubMed     Abstract available

  6. SATTUI SE, Lieber SB
    Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220991. doi: 10.3899/jrheum.220991.
    PubMed     Abstract available

    The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1188-1190.

    October 2022
    Baseline Gene Expression Analysis in the Peripheral Blood of Patients With Rheumatoid Arthritis as an Important Supplement to Standard Composite Measure.
    J Rheumatol. 2022 Oct 15. pii: jrheum.220795. doi: 10.3899/jrheum.220795.
    PubMed     Abstract available

  9. ISNARDI CA, Cerda OL, Landi M, Cruces L, et al
    Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
    J Rheumatol. 2022 Oct 1. pii: jrheum.220469. doi: 10.3899/jrheum.220469.
    PubMed     Abstract available

  10. GLINTBORG B, Jensen DV, Terslev L, Hendricks O, et al
    Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    J Rheumatol. 2022;49:1163-1172.
    PubMed     Abstract available

    September 2022
  11. DESSEIN PH, Stanwix AE, Solomon A
    How Could Physical Activity Reduce Inflammation and Inflammatory Gene Expression in Rheumatoid Arthritis?
    J Rheumatol. 2022 Sep 15. pii: jrheum.220788. doi: 10.3899/jrheum.220788.
    PubMed     Abstract available

  12. VAN DIJK B, van der Helm-van Mil A
    Delayed Referral of Female Patients With Rheumatoid Arthritis: Where Are We Now? A Study Spanning 3 Decades.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220429. doi: 10.3899/jrheum.220429.
    PubMed     Abstract available

  13. FAYET F, Darmant N, Rodere M, Fan A, et al
    The Practice of Argentine Tango in Patients With Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study, a Positive Experience.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220103. doi: 10.3899/jrheum.220103.
    PubMed     Abstract available

    The Prism of Inequity: Health Disparities in Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1070-1071.

    Taking the Long View: Patients Perceive Benefits and Risks of Treatment as Multidimensional.
    J Rheumatol. 2022;49:971-973.

    August 2022
  16. FERRAZ-AMARO I, Sheikh A, Polack B, Giles JT, et al
    Articular (18)Fluorodeoxyglucose Uptake Is Associated with Clinically Assessed Swollen Joint Count in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220231. doi: 10.3899/jrheum.220231.
    PubMed     Abstract available

  17. MENG CF, Rajesh DA, Jannat-Khah DP, Jivanelli B, et al
    Can Patients with Controlled Rheumatoid Arthritis Taper Methotrexate from Targeted Therapy and Sustain Remission? A Systematic Review and Meta-analysis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220152. doi: 10.3899/jrheum.220152.
    PubMed     Abstract available

  18. BAGGETT K, Brandon TG, Xiao R, Valenzuela Z, et al
    Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2022;49:935-941.
    PubMed     Abstract available

    July 2022
  19. HAZLEWOOD GS, Pardo JP, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs.
    J Rheumatol. 2022 Jul 15. pii: jrheum.220209. doi: 10.3899/jrheum.220209.
    PubMed     Abstract available

  20. KODISHALA C, Hulshizer CA, Kronzer VL, Davis JM 3rd, et al
    Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study.
    J Rheumatol. 2022 Jul 15. pii: jrheum.220200. doi: 10.3899/jrheum.220200.
    PubMed     Abstract available

  21. PATTERSON SL, Sun S, Rychkov D, Katz P, et al
    Physical Activity Associates with Lower Systemic Inflammatory Gene Expression in Rheumatoid Arthritis.
    J Rheumatol. 2022 Jul 1. pii: jrheum.220050. doi: 10.3899/jrheum.220050.
    PubMed     Abstract available

    June 2022
  22. DAVIS JM 3RD
    The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220412. doi: 10.3899/jrheum.220412.
    PubMed     Abstract available

  23. AVOUAC J, Molto A, Frantz C, Wanono S, et al
    Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220073. doi: 10.3899/jrheum.220073.
    PubMed     Abstract available

  24. MOORE MN, Wallace BI, Song J, Muhammad LN, et al
    Correlation of fibromyalgia survey questionnaire and quantitative sensory testing among patients with active rheumatoid arthritis.
    J Rheumatol. 2022 Jun 1. pii: jrheum.220046. doi: 10.3899/jrheum.220046.
    PubMed     Abstract available

  25. DARABIAN S, Wade JP, Kur J, Wade SD, et al
    Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    J Rheumatol. 2022;49:558-565.
    PubMed     Abstract available

  26. NASH P
    Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available

  27. BESSETTE L, Mysler E, Kinch CD, Kwok K, et al
    Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
    J Rheumatol. 2022;49:566-576.
    PubMed     Abstract available

  28. LUBBERTS E, Scher JU, FitzGerald O
    Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available

    May 2022
  29. CAGNOTTO G, Jacobsson THL, Rydell E, Eberhard A, et al
    Male Sex Predicts a Favorable Outcome in Early ACPA-negative Rheumatoid Arthritis: Data From An Observational Study.
    J Rheumatol. 2022 May 2. pii: jrheum.211199. doi: 10.3899/jrheum.211199.
    PubMed     Abstract available

  30. DIRENZO DD, Robinson S, Bingham CO 3rd, Baer AN, et al
    PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjogren Syndrome.
    J Rheumatol. 2022;49:470-474.
    PubMed     Abstract available

  31. EDER L, Croxford R, Drucker AM, Mendel A, et al
    COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    J Rheumatol. 2022;49:523-530.
    PubMed     Abstract available

  32. WIDDIFIELD J, Eder L, Chen S, Kwong JC, et al
    COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
    J Rheumatol. 2022;49:531-536.
    PubMed     Abstract available

    April 2022
  33. LIAO PY, Liao SL, Liaw YP
    Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.211278. doi: 10.3899/jrheum.211278.
    PubMed     Abstract available

  34. VERWEIJ NJF, de Jongh J, Ter Wee MM, Zwezerijnen GJC, et al
    Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.210928. doi: 10.3899/jrheum.210928.
    PubMed     Abstract available

  35. ZICKUHR L, Mandell BF
    Rheumatology Education Needs a Splash of Color.
    J Rheumatol. 2022;49:343-345.

    March 2022
  36. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
    Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
    PubMed     Abstract available

  37. HADWEN B, Yu R, Cairns E, Barra L, et al
    Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
    PubMed     Abstract available

  38. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status.
    J Rheumatol. 2022;49:340.

  39. HAZLEWOOD GS, Schieir O, Bykerk V, Mujaab K, et al
    Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey.
    J Rheumatol. 2022 Mar 1. pii: jrheum.210688. doi: 10.3899/jrheum.210688.
    PubMed     Abstract available

  40. KREMER JM, Reed G, Pappas DA, Kane K, et al
    Dr. Kremer et al reply.
    J Rheumatol. 2022;49:338-339.

    February 2022
  41. MOVAHEDI M, Cesta A, Li X, Keystone EC, et al
    Physician and Patient Reported Effectiveness are similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data from a Rheumatoid Arthritis Registry.
    J Rheumatol. 2022 Feb 15. pii: jrheum.211066. doi: 10.3899/jrheum.211066.
    PubMed     Abstract available

  42. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
    Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients.
    J Rheumatol. 2022 Feb 1. pii: jrheum.211270. doi: 10.3899/jrheum.211270.
    PubMed     Abstract available

  43. DE ANGELIS R, Giuggioli D, Bajocchi G, Dagna L, et al
    Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
    J Rheumatol. 2022;49:176-185.
    PubMed     Abstract available

  44. BERARDICURTI O, Pavlych V, Cola ID, Ruscitti P, et al
    Long-term Safety of Rituximab in Primary Sjogren Syndrome: The Experience of a Single Center.
    J Rheumatol. 2022;49:171-175.
    PubMed     Abstract available

  45. KAWADA T
    Smoking, Obesity, and Risk of Primary Sjogren Syndrome.
    J Rheumatol. 2022;49:234.

  46. BERTI A, Cornec D, Crowson CS, Matteson EL, et al
    Dr. Berti et al reply.
    J Rheumatol. 2022;49:234.

  47. GRIFFITHS H, Smith T, Mack C, Leadbetter J, et al
    Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset.
    J Rheumatol. 2022;49:150-156.
    PubMed     Abstract available

    January 2022
  48. PAZMINO S, Lovik A, Westhovens R, Verschueren P, et al
    Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication.
    J Rheumatol. 2022 Jan 15. pii: jrheum.210871. doi: 10.3899/jrheum.210871.
    PubMed     Abstract available

  49. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
    Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
    J Rheumatol. 2022;49:122.

    December 2021
  50. KREMER JM, Pappas DA, Kane K, Greenberg J, et al
    The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.
    J Rheumatol. 2021;48:1776-1783.
    PubMed     Abstract available

    November 2021
  51. WIENS D, Smolik I, Meng X, Anaparti V, et al
    Functional disability to evaluate the risk of arthritis in First-degree relatives of Rheumatoid Arthritis patients.
    J Rheumatol. 2021 Nov 1. pii: jrheum.210614. doi: 10.3899/jrheum.210614.
    PubMed     Abstract available

  52. AGUIRRE A, Yazdany J
    Hepatitis B Screening Before Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug Therapy: Many Roads to Improvement.
    J Rheumatol. 2021 Nov 1. pii: jrheum.211000. doi: 10.3899/jrheum.211000.
    PubMed     Abstract available

    October 2021
  53. PINCUS T, Bergman MJ, Yazici Y
    Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?
    J Rheumatol. 2021 Oct 15. pii: jrheum.210953. doi: 10.3899/jrheum.210953.
    PubMed     Abstract available

  54. KRONZER VL, Huang W, Zaccardelli A, Crowson CS, et al
    Association of sinusitis and upper respiratory tract diseases with incident rheumatoid arthritis: A case-control study.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210580. doi: 10.3899/jrheum.210580.
    PubMed     Abstract available

  55. STUDENIC P, Radner H
    Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis.
    J Rheumatol. 2021 Oct 1. pii: jrheum.210984. doi: 10.3899/jrheum.210984.
    PubMed     Abstract available

  56. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission after Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by non-Medicare and Medicare Payer Status.
    J Rheumatol. 2021 Oct 1. pii: jrheum.201370. doi: 10.3899/jrheum.201370.
    PubMed     Abstract available

    September 2021
  57. VAN DER HEIJDE D, Kartman CE, Xie L, Beattie S, et al
    Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND.
    J Rheumatol. 2021 Sep 15. pii: jrheum.210346. doi: 10.3899/jrheum.210346.
    PubMed     Abstract available

  58. FERNANDES BM, Pereira JM, Pereira PR, Bernardes M, et al
    Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept.
    J Rheumatol. 2021 Sep 15. pii: jrheum.210540. doi: 10.3899/jrheum.210540.
    PubMed     Abstract available

    The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review.
    J Rheumatol. 2021 Sep 1. pii: jrheum.210822. doi: 10.3899/jrheum.210822.
    PubMed     Abstract available

  60. BEKKER CL, Bossina S, de Vera MA, Bartlett SJ, et al
    Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study.
    J Rheumatol. 2021;48:1480-1487.
    PubMed     Abstract available

    August 2021
  61. WANG X, Hefton A, Ni K, Ukadike KC, et al
    Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
    PubMed     Abstract available

  62. MEER E, Thrastardottir T, Wang X, Dubreuil M, et al
    Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies.
    J Rheumatol. 2021 Aug 1. pii: jrheum.210006. doi: 10.3899/jrheum.210006.
    PubMed     Abstract available

  63. HAZLEWOOD GS, Bombardier C, Li X, Movahedi M, et al
    Heterogeneity in patient characteristics and differences in treatment across four Canadian rheumatoid arthritis cohorts.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201688. doi: 10.3899/jrheum.201688.
    PubMed     Abstract available

    July 2021
  64. KAHLER J, Mastarone G, Matsumoto R, ZuZero D, et al
    It may help you to know. . .": The early phase qualitative development of a rheumatoid arthritis goal elicitation tool.
    J Rheumatol. 2021 Jul 1. pii: jrheum.201615. doi: 10.3899/jrheum.201615.
    PubMed     Abstract available

  65. JARROT PA, Arcani R, Darmon O, Roudier J, et al
    Axial Articular Manifestations in Primary Sjogren Syndrome: Association With Spondyloarthritis.
    J Rheumatol. 2021;48:1037-1046.
    PubMed     Abstract available

  66. ORNETTI P, Guillier D, Jeudy G
    Perforating Rheumatoid Nodule Mimicking Malignant Soft-tissue Mass of the Forearm.
    J Rheumatol. 2021;48:1103.

  67. YUN H, Xie F, Chen L, Yang S, et al
    Evaluation of the Effect of Diabetes on Rheumatoid Arthritis-related Outcomes in an Electronic Health Record-based Rheumatology Registry.
    J Rheumatol. 2021;48:992-1001.
    PubMed     Abstract available

  68. MCCOY SS, Bartels CM, Saldanha IJ, Bunya VY, et al
    National Sjogren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
    J Rheumatol. 2021;48:1029-1036.
    PubMed     Abstract available

    June 2021
    Is the Gap in Incidence of Cardiovascular Events in Rheumatoid Arthritis Really Closing?
    J Rheumatol. 2021 Jun 15. pii: jrheum.210366. doi: 10.3899/jrheum.210366.
    PubMed     Abstract available

  70. JANSEN G, de Rotte MCFJ, de Jonge R
    Smoking and Methotrexate Inefficacy in Rheumatoid Arthritis: What About Underlying Molecular Mechanisms?
    J Rheumatol. 2021 Jun 15. pii: jrheum.210217. doi: 10.3899/jrheum.210217.
    PubMed     Abstract available

  71. GOULIELMOS GN, Zervou MI
    Risk of Venous Thromboembolism in Ankylosing Spondylitis and Rheumatoid Arthritis: Genetic Aspects.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210131. doi: 10.3899/jrheum.210131.
    PubMed     Abstract available

  72. FERREIRA RJO, Landewe RBM, da Silva JAP
    Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?
    J Rheumatol. 2021 Jun 1. pii: jrheum.210050. doi: 10.3899/jrheum.210050.
    PubMed     Abstract available

    Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210224. doi: 10.3899/jrheum.210224.
    PubMed     Abstract available

    Cutting the "Gordian Knot" - Cardiac Involvement in Primary Sjogren Syndrome.
    J Rheumatol. 2021;48:802-803.

  75. LINDBERG H, Colliander C, Nise L, Dahlqvist J, et al
    Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis With Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study.
    J Rheumatol. 2021;48:894-897.
    PubMed     Abstract available

  76. NISHIWAKI A, Kobayashi H, Ikumi N, Kobayashi Y, et al
    Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjogren Syndrome Assessed by a Cardiac Magnetic Resonance Approach.
    J Rheumatol. 2021;48:859-866.
    PubMed     Abstract available

    May 2021
  77. JACOBS JWG, Verhoeven MMA, Welsing PMJ
    Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests.
    J Rheumatol. 2021 May 15. pii: jrheum.201510. doi: 10.3899/jrheum.201510.
    PubMed     Abstract available

  78. PIANAROSA E, Hazlewood G, Thomas M, Hsiao R, et al
    Supporting Equity in Rheumatoid Arthritis Outcomes in Canada: Population-Specific Factors in Patient-Centered Care.
    J Rheumatol. 2021 May 15. pii: jrheum.210016. doi: 10.3899/jrheum.210016.
    PubMed     Abstract available

  79. RAMPES S, Patel V, Bosworth A, Jacklin C, et al
    Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis.
    J Rheumatol. 2021 May 15. pii: jrheum.201439. doi: 10.3899/jrheum.201439.
    PubMed     Abstract available

  80. TANIGUCHI Y, Kimata T
    Yellow Nail Syndrome Associated With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:785.

  81. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
    Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (Biobadabrasil).
    J Rheumatol. 2021 May 1. pii: jrheum.201248. doi: 10.3899/jrheum.201248.
    PubMed     Abstract available

  82. JOHANSSON FD, Collins JE, Yau V, Guan H, et al
    Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning.
    J Rheumatol. 2021 May 1. pii: jrheum.201626. doi: 10.3899/jrheum.201626.
    PubMed     Abstract available

  83. LIU Y, Zhang S, Xia CS, Chen J, et al
    Elevated Granulocyte Colony-stimulating Factor Levels in Patients With Active Phase of Adult-onset Still Disease.
    J Rheumatol. 2021;48:664-668.
    PubMed     Abstract available

    April 2021
  84. TANAKA Y, Takeuchi T, Soen S, Yamanaka H, et al
    Effects of denosumab in Japanese rheumatoid arthritis patients treated with conventional anti-rheumatic drugs: 36-month extension of a phase 3 study.
    J Rheumatol. 2021 Apr 15. pii: jrheum.201376. doi: 10.3899/jrheum.201376.
    PubMed     Abstract available

  85. KARLSSON SUNDBAUM J, Arkema EV, Bruchfeld J, Jonsson J, et al
    Tuberculosis in biologic-naive patients with rheumatoid arthritis - risk factors and tuberculosis characteristics.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201251. doi: 10.3899/jrheum.201251.
    PubMed     Abstract available

  86. LIANG YT, Leong PY, Wei JC
    Questions on the Bidirectional Relationship Between Primary Sjogren Syndrome and Non-Hodgkin Lymphoma.
    J Rheumatol. 2021;48:620.

    March 2021
    Ultrasonography of the Salivary Gland in Primary Sjogren Syndrome: Usefulness to Phenotype the Patients.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201433. doi: 10.3899/jrheum.201433.
    PubMed     Abstract available

    January 2021
    Questions From Patients and Doctors on Negative Minor Salivary Gland Biopsy in Sjogren Syndrome.
    J Rheumatol. 2021;48:149.

  89. MONSALVE DM, Anaya JM
    Drs. Monsalve and Anaya reply.
    J Rheumatol. 2021;48:149.

    October 2020
  90. MOSSEL E, van Nimwegen JF, Stel AJ, Wijnsma RF, et al
    Clinical phenotyping of primary Sjogren's patients using salivary gland ultrasonography - data from the RESULT cohort.
    J Rheumatol. 2020 Oct 1. pii: jrheum.200482. doi: 10.3899/jrheum.200482.
    PubMed     Abstract available

    August 2020
  91. GROSSE J, Allado E, Albuisson E, Pierreisnard A, et al
    The USSe (UltraSound Score for Erosions) in the evaluation of bone erosions in RA compared to the SHSe (Van der Heijde-modified Sharp score for erosions).
    J Rheumatol. 2020 Aug 15. pii: jrheum.200286. doi: 10.3899/jrheum.200286.
    PubMed     Abstract available

    May 2020
  92. SAHINKAYA Y, Mumcu G, Ozdemir FT, Kurus RE, et al
    Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health Related Quality of Life in Sjogren's syndrome?
    J Rheumatol. 2020 May 1. pii: jrheum.190849. doi: 10.3899/jrheum.190849.
    PubMed     Abstract available

    February 2020
  93. WARD JM, Hess JN, Davis LS
    Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    J Rheumatol. 2020;47:298-299.

    September 2019
  94. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
    Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
    PubMed     Abstract available

    August 2019
  95. RENNER N, Kleyer A, Kronke G, Simon D, et al
    T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in RA.
    J Rheumatol. 2019 Aug 15. pii: jrheum.180728. doi: 10.3899/jrheum.180728.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.